Literature DB >> 2546313

Urolithiasis inhibitors and calculus nucleation.

F Grases1, J J Gil, A Conte.   

Abstract

The possible inhibitors of heterogeneous nucleation were investigated. The effects of magnesium, pyrophosphate, citrate and Chondroitin Sulphate on calcium phosphate or uric acid heterogeneous nucleation of calcium oxalate were studied. It was found that whereas magnesium, pyrophosphate and citrate acted as effective inhibitors in the presence of calcium phosphate as heterogeneous nucleant, only chondroitin sulphate manifested important inhibitory effects when uric acid was the heterogeneous nucleant.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2546313     DOI： 10.1007/BF00256244

Source DB:  PubMed          Journal:  Urol Res        ISSN： 0300-5623


  6 in total

1.  Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate.

Authors:  C Y Pak; L H Arnold
Journal:  Proc Soc Exp Biol Med       Date:  1975-09

2.  Simple method for the study of heterogeneous nucleation in calcium oxalate urolithiasis.

Authors:  F Grases; A Conte; J J Gil
Journal:  Br J Urol       Date:  1988-06

3.  Calcium phosphate formation in vitro. I. Factors affecting initial phase separation.

Authors:  J D Termine; A S Posner
Journal:  Arch Biochem Biophys       Date:  1970-10       Impact factor: 4.013

4.  The expectation of free and fixed particles in urinary stone disease.

Authors:  B Finlayson; F Reid
Journal:  Invest Urol       Date:  1978-05

5.  Urate does not influence the formation of calcium oxalate crystals in whole human urine at pH 5.3.

Authors:  P C Hallson; G A Rose; S Sulaiman
Journal:  Clin Sci (Lond)       Date:  1982-04       Impact factor: 6.124

6.  Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score.

Authors:  C Y Pak; R A Galosy
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965
  6 in total
  5 in total

1.  The importance of crystallization processes in understanding of stone formation.

Authors:  J M Baumann
Journal:  Urol Res       Date:  1989

2.  The relation between orthophosphate and pyrophosphate in normal subjects and in patients with urolithiasis.

Authors:  A Conte; P Roca; C Genestar; F Grases
Journal:  Urol Res       Date:  1989

3.  Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.

Authors:  F Grases; A Costa-Bauzá; J G March; L Masárová
Journal:  Urol Res       Date:  1991

4.  Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.

Authors:  F Atmani; B Lacour; T Drüeke; M Daudon
Journal:  Urol Res       Date:  1993-01

5.  Urolithiasis, inhibitors and promoters.

Authors:  F Grases; A Conte
Journal:  Urol Res       Date:  1992
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.